Table 4

Multivariable analysis for cause-specific survival after ILR

CharacteristicAdjusted HR
(95% CI)
P value
Age at primary surgery (years)*1.13 (0.80 to 1.58)0.49
FIGO grade0.028
 2–33.24 (1.13 to 9.25)
 Yes2.10 (1.15 to 3.86)
Treatment of ILR0.0499
 Observation or hormonal therapy only2.36 (0.90 to 6.14)
 Chemotherapy and/or radiotherapy2.83 (1.23 to 6.52)
 Surgery±other treatmentsReference
  • *HR per 10-year increase for age.

  • FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion; ILR, isolated lymphatic recurrence.